您的位置: 首页 > 农业专利 > 详情页

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
专利权人:
IMMATICS BIOTECHNOLOGIES GMBH
发明人:
Toni WEINSCHENK,Andrea MAHR,Jens FRITSCHE,Phillip MUELLER,Anita WIEBE,Sarah KUTSCHER
申请号:
US15917098
公开号:
US20180207252A1
申请日:
2018.03.09
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A method of treating a patient who has a cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize the cancer cells in the patient that aberrantly express a peptide consisting of the amino acid sequence of GVYDGEEHSV (SEQ ID NO: 303), in which the peptide is in a complex with an MHC molecule.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充